Herbert E. Klei
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Enzyme Structure and Function, Biochemical and Molecular Research, Hepatitis C virus research, HIV/AIDS drug development and treatment, Biofuel production and bioconversion
Most-Cited Works
- → Discovery of N-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays(2004)1,285 cited
- → The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants(2006)678 cited
- → Destruction of aromatic pollutants by UV light catalyzed oxidation with hydrogen peroxide(1989)149 cited
- → Automated ligand fitting by core-fragment fitting and extension into density(2006)129 cited
- → Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation(2008)127 cited
- → The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)110 cited